Patents by Inventor Quanjie LI

Quanjie LI has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240023523
    Abstract: A method for polyculture of Alosa sapidissima and Macrobrachium rosenbergii by a floating net fishing device and a greenhouse earthen pond includes: S1: providing a slope on an inner wall of a pond, and providing a feeding channel on the slope for survival and attachment of the Macrobrachium rosenbergii; S2: building a greenhouse on the pond, raising a water temperature to a set temperature, then putting Macrobrachium rosenbergii larvae, and putting Alosa sapidissima fry into the pond for polyculture in different periods; and S3: fishing in batches through a floating net: firstly, fishing the Alosa sapidissima fry in middle and upper layers, and then fishing the Macrobrachium rosenbergii in middle and lower layers.
    Type: Application
    Filed: July 25, 2023
    Publication date: January 25, 2024
    Inventors: Gangchun XU, Zhijuan NIE, Nailin SHAO, Yao ZHENG, Jiancao GAO, Yi SUN, Haojun ZHU, Jinliang DU, Liping CAO, Jun GAO, Quanjie LI, Jiawen HU
  • Publication number: 20230321079
    Abstract: The present invention provides use of berbamine dihydrochloride in preparation of an Ebola virus inhibitor. In the present invention, the primed glycoprotein of the Ebola virus (EBOV-GPcl) is taken as a target site, and an antiviral active compound with the capability of binding to the EBOV-GPcl, i.e., berbamine dihydrochloride, is obtained through structure-based virtual screening. Berbamine dihydrochloride can specifically inhibit the entry of an Ebola recombinant virus by binding to the target protein EBOV-GPcl, thereby achieving the effect of anti-Ebola virus infection. The half-maximum effect concentration (EC50) of berbamine dihydrochloride against EBOV is 0.49 ?M, which indicates that berbamine dihydrochloride has a strong inhibition effect on EBOV.
    Type: Application
    Filed: April 10, 2023
    Publication date: October 12, 2023
    Inventors: Shan Cen, Quanjie Li, Dongrong Yi, Yi Shi, Han Wang, Jinming Zhou
  • Patent number: 11654141
    Abstract: The present invention provides use of berbamine dihydrochloride in preparation of an Ebola virus inhibitor. In the present invention, the primed glycoprotein of the Ebola virus (EBOV-GPcl) is taken as a target site, and an antiviral active compound with the capability of binding to the EBOV-GPcl, i.e., berbamine dihydrochloride, is obtained through structure-based virtual screening. Berbamine dihydrochloride can specifically inhibit the entry of an Ebola recombinant virus by binding to the target protein EBOV-GPcl, thereby achieving the effect of anti-Ebola virus infection. The half-maximum effect concentration (EC50) of berbamine dihydrochloride against EBOV is 0.49 ?M, which indicates that berbamine dihydrochloride has a strong inhibition effect on EBOV.
    Type: Grant
    Filed: June 19, 2019
    Date of Patent: May 23, 2023
    Assignee: Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences
    Inventors: Shan Cen, Quanjie Li, Dongrong Yi, Yi Shi, Han Wang, Jinming Zhou
  • Patent number: 11647736
    Abstract: An engineered recirculating aquaculture fish pond and a fish culture method are provided. The engineered recirculating aquaculture fish pond is simple to operate, has strong adaptability to different culture environments or culture varieties, and is not only suitable for large-scale aquaculture enterprises but also suitable for small-scale farmers. An aeration water lifting device is designed to simultaneously perform aeration and drainage, which can reduce the use of electric equipment, decrease the production and maintenance cost, improve the cost performance of single equipment, and save the internal use space of the pond. Nozzles are arranged in more than two directions, which is convenient for performing aeration in different directions, uniformly dispersing impurities carried in water in a deep ditch, intercepting to reduce local blockage, improving a single utilization rate of an intercept structure, and preventing heavier impurities from accumulating at a channel bottom of the deep ditch.
    Type: Grant
    Filed: April 28, 2022
    Date of Patent: May 16, 2023
    Assignee: FRESHWATER FISHERIES RESEARCH CENTER, CHINESE ACADEMY OF FISHERY SCIENCES
    Inventors: Gangchun Xu, Hongxia Li, Zhijuan Nie, Quanjie Li, Changyou Song, Lin Zhang, Yuan Yuan, Haojun Zhu, Yi Sun
  • Publication number: 20230090467
    Abstract: An engineered recirculating aquaculture fish pond and a fish culture method are provided. The engineered recirculating aquaculture fish pond is simple to operate, has strong adaptability to different culture environments or culture varieties, and is not only suitable for large-scale aquaculture enterprises but also suitable for small-scale farmers. An aeration water lifting device is designed to simultaneously perform aeration and drainage, which can reduce the use of electric equipment, decrease the production and maintenance cost, improve the cost performance of single equipment, and save the internal use space of the pond. Nozzles are arranged in more than two directions, which is convenient for performing aeration in different directions, uniformly dispersing impurities carried in water in a deep ditch, intercepting to reduce local blockage, improving a single utilization rate of an intercept structure, and preventing heavier impurities from accumulating at a channel bottom of the deep ditch.
    Type: Application
    Filed: April 28, 2022
    Publication date: March 23, 2023
    Inventors: GANGCHUN XU, HONGXIA LI, ZHIJUAN NIE, QUANJIE LI, CHANGYOU SONG, LIN ZHANG, YUAN YUAN, HAOJUN ZHU, YI SUN
  • Publication number: 20200281916
    Abstract: The present invention provides use of berbamine dihydrochloride in preparation of an Ebola virus inhibitor. In the present invention, the primed glycoprotein of the Ebola virus (EBOV-GPcl) is taken as a target site, and an antiviral active compound with the capability of binding to the EBOV-GPcl, i.e., berbamine dihydrochloride, is obtained through structure-based virtual screening. Berbamine dihydrochloride can specifically inhibit the entry of an Ebola recombinant virus by binding to the target protein EBOV-GPcl, thereby achieving the effect of anti-Ebola virus infection. The half-maximum effect concentration (EC50) of berbamine dihydrochloride against EBOV is 0.49 ?M, which indicates that berbamine dihydrochloride has a strong inhibition effect on EBOV.
    Type: Application
    Filed: June 19, 2019
    Publication date: September 10, 2020
    Applicant: INSTITUTE OF MEDICINAL BIOTECHNOLOGY, CHINESE ACADEMY OF MEDICAL SCIENCES
    Inventors: Shan CEN, Quanjie LI, Dongrong YI, Yi SHI, Han WANG, Jinming ZHOU